In last trading session, AVITA Medical Inc (NASDAQ:RCEL) saw 0.3 million shares changing hands with its beta currently measuring 1.57. Company’s recent per share price level of $6.46 trading at $0.09 or 1.41% at ring of the bell on the day assigns it a market valuation of $160.47M. That closing price of RCEL’s stock is at a discount of -119.2% from its 52-week high price of $14.16 and is indicating a premium of 4.49% from its 52-week low price of $6.17. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.43 million shares which gives us an average trading volume of 234.19K if we extend that period to 3-months.
For AVITA Medical Inc (RCEL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.88. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
AVITA Medical Inc (NASDAQ:RCEL) trade information
Upright in the green during last session for gaining 1.41%, in the last five days RCEL remained trading in the red while hitting it’s week-highest on Tuesday, 05/13/25 when the stock touched $6.46 price level, adding 13.06% to its value on the day. AVITA Medical Inc’s shares saw a change of -49.53% in year-to-date performance and have moved -7.32% in past 5-day. AVITA Medical Inc (NASDAQ:RCEL) showed a performance of -28.38% in past 30-days. Number of shares sold short was 2.97 million shares which calculate 15.54 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 14 to the stock, which implies a rise of 53.86% to its current value. Analysts have been projecting 14 as a low price target for the stock while placing it at a high target of 14. It follows that stock’s current price would drop -116.72% in reaching the projected high whereas dropping to the targeted low would mean a loss of -116.72% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -88.92% during past 5 years.
AVITA Medical Inc (NASDAQ:RCEL)’s Major holders
Insiders are in possession of 0.82% of company’s total shares while institution are holding 26.81 percent of that, with stock having share float percentage of 27.03%. Investors also watch the number of corporate investors in a company very closely, which is 26.81% institutions for AVITA Medical Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at RCEL for having 1.78 million shares of worth $14.13 million. And as of 2024-06-30, it was holding 7.0222 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 1.4 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.4945 of outstanding shares, having a total worth of $11.05 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 800.72 shares of worth $5.17 million or 3.03% of the total outstanding shares. The later fund manager was in possession of 669.39 shares on Mar 31, 2025 , making its stake of worth around $4.32 million in the company or a holder of 2.53% of company’s stock.
